1. Home
  2. OPFI vs TVGN Comparison

OPFI vs TVGN Comparison

Compare OPFI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPFI
  • TVGN
  • Stock Information
  • Founded
  • OPFI 2009
  • TVGN 2020
  • Country
  • OPFI United States
  • TVGN United States
  • Employees
  • OPFI N/A
  • TVGN N/A
  • Industry
  • OPFI Finance: Consumer Services
  • TVGN Blank Checks
  • Sector
  • OPFI Finance
  • TVGN Finance
  • Exchange
  • OPFI Nasdaq
  • TVGN Nasdaq
  • Market Cap
  • OPFI 174.4M
  • TVGN 174.4M
  • IPO Year
  • OPFI N/A
  • TVGN N/A
  • Fundamental
  • Price
  • OPFI $9.75
  • TVGN $1.38
  • Analyst Decision
  • OPFI Buy
  • TVGN
  • Analyst Count
  • OPFI 2
  • TVGN 0
  • Target Price
  • OPFI $7.50
  • TVGN N/A
  • AVG Volume (30 Days)
  • OPFI 1.1M
  • TVGN 1.7M
  • Earning Date
  • OPFI 03-06-2025
  • TVGN 02-20-2025
  • Dividend Yield
  • OPFI N/A
  • TVGN N/A
  • EPS Growth
  • OPFI 775.86
  • TVGN N/A
  • EPS
  • OPFI 0.38
  • TVGN N/A
  • Revenue
  • OPFI $260,661,000.00
  • TVGN N/A
  • Revenue This Year
  • OPFI N/A
  • TVGN N/A
  • Revenue Next Year
  • OPFI $6.51
  • TVGN N/A
  • P/E Ratio
  • OPFI $25.79
  • TVGN N/A
  • Revenue Growth
  • OPFI 23.85
  • TVGN N/A
  • 52 Week Low
  • OPFI $2.35
  • TVGN $0.26
  • 52 Week High
  • OPFI $10.00
  • TVGN $21.09
  • Technical
  • Relative Strength Index (RSI)
  • OPFI 69.08
  • TVGN 57.09
  • Support Level
  • OPFI $6.81
  • TVGN $1.20
  • Resistance Level
  • OPFI $8.73
  • TVGN $1.57
  • Average True Range (ATR)
  • OPFI 0.68
  • TVGN 0.16
  • MACD
  • OPFI 0.16
  • TVGN 0.06
  • Stochastic Oscillator
  • OPFI 92.16
  • TVGN 71.21

About OPFI OppFi Inc.

OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.

About TVGN Tevogen Bio Holdings Inc. Common Stock

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: